bezafibrate has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamoto, K; Chowdhury, PS; Honjo, T; Kumar, A | 1 |
| Mulligan, HD; Tisdale, MJ | 1 |
| Hirst, DG | 1 |
3 other study(ies) available for bezafibrate and Experimental Neoplasms
| Article | Year |
|---|---|
PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Differentiation; Fatty Acids; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondria; Molecular Targeted Therapy; Neoplasms, Experimental; Oxidation-Reduction; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptors; Programmed Cell Death 1 Receptor; T-Lymphocytes, Cytotoxic | 2018 |
Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.
Topics: Animals; Bezafibrate; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Triolein; Tumor Cells, Cultured | 1991 |
Tumour radiosensitization by clofibrate and its analogs: possible mechanisms.
Topics: Animals; Bezafibrate; Clofibrate; Combined Modality Therapy; Etanidazole; Female; Hypoxia; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Regional Blood Flow | 1990 |